KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Debt Ratio (2019 - 2025)

Vir Biotechnology (VIR) has disclosed Debt Ratio for 5 consecutive years, with 0.01 as the latest value for Q1 2025.

  • Quarterly Debt Ratio changed N/A to 0.01 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was 0.01 through Mar 2025, changed N/A year-over-year, with the annual reading at 0.01 for FY2024, N/A changed from the prior year.
  • Debt Ratio hit 0.01 in Q1 2025 for Vir Biotechnology, up from 0.01 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.06 in Q3 2021 to a low of 0.01 in Q4 2024.
  • Historically, Debt Ratio has averaged 0.03 across 3 years, with a median of 0.02 in 2021.
  • Biggest YoY gain for Debt Ratio was 254.33% in 2021; the steepest drop was 4.19% in 2021.
  • Year by year, Debt Ratio stood at 0.06 in 2021, then tumbled by 79.72% to 0.01 in 2024, then increased by 16.56% to 0.01 in 2025.
  • Business Quant data shows Debt Ratio for VIR at 0.01 in Q1 2025, 0.01 in Q4 2024, and 0.06 in Q3 2021.